Picture EBD Group BioPharm America 2018 Boston Speakers 600x60px
Document › Details

Proteome Sciences plc. (12/4/13). "Press Release: Trading Update".

Organisations Organisation Proteome Sciences plc
  Group Proteome Sciences (Group)
  Organisation 2 Thermo Fisher Scientific Inc. (NYSE: TMO)
  Group Thermo Fisher (Group)
Products Product TMT® (isobaric tandem mass tag) technology
  Product 2 PS Biomarker Services™
Index term Index term Thermo Fisher–Proteome Sciences: TMT technology, 201306– collab $2.1m developm cancer pathway profiling assays using MS3 TMT technology with Orbitrap
Persons Person Pearce, Christopher (Proteome Sciences 201606– Non-executive Chairman before CEO)
  Person 2 Malthouse, James (Proteome Sciences 201006 Finance Director)

The Directors would like to update shareholders on the Company's trading activities. We are pleased to have made good progress with the SysQuant® platform and in developing new targeted assays over the last six months and successfully completed a number of customer pilot studies. Revenue for 2013 is expected to show a significant increase over 2012, driven by increased demand for PS Biomarker Services™, SysQuant®, TMT® and the contract announced with Thermo Fisher Scientific.

Sales lead times however have taken longer than anticipated and the timing and revenue from a number of other contracts expected in the fourth quarter has been delayed and is now projected to materialise in 2014. Our pipeline and the level of interest continue to grow as customers shift to large-scale projects following the successful pilot studies already completed.

Our core activities are performing well and we remain confident about our prospects.

- Ends -

For further information please contact:

Proteome Sciences plc
Christopher Pearce, Chief Executive Officer
Tel: +44 (0)1932 865065
Dr. Ian Pike, Chief Operating Officer
James Malthouse, Finance Director

Nominated Adviser
Stephen Keys/Camilla Hume
Tel: +44 (0)20 7397 8900

Public Relations
IKON Associates
Adrian Shaw
Tel: +44 (0)1483 271291

Notes to Editors:

About Proteome Sciences

Proteome Sciences is a global leader in applied proteomics and peptidomics offering high sensitivity, proprietary technologies for protein and peptide biomarker discovery, validation and assay development. Its PS Biomarker Services™ uses isobaric and isotopic Tandem Mass Tag® (TMT®) workflows developed on the latest Orbitrap® Velos and TSQ Vantage mass spectrometers to deliver rapid, robust and reproducible biomarker assay development for customers in the pharmaceutical, diagnostic and biotechnology sectors. Services are provided from its ISO 9001: 2008 accredited facilities in Frankfurt, Germany. By combining Selected Reaction Monitoring (SRM) and TMT® workflows highly multiplexed assays can be developed rapidly and are suitable for screening hundreds of candidate biomarkers in larger validation studies and can be transferred for immunoassay development. The Company's own research has discovered a large number of novel protein biomarkers in key human diseases and is focused mainly in neurological/neurodegenerative conditions and in cancer. It has discovered and patented blood biomarkers, including Alzheimer's disease, stroke, brain damage and lung cancer for diagnostic and treatment applications that are available for license or are already outlicensed. Proteome Sciences, based in Cobham, UK, with facilities in London and Frankfurt, delivers outsourced proteomics services and proprietary biomarkers/biomarker assays to pharmaceutical, biotechnology and diagnostics companies.

Record changed: 2016-03-19


Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Proteome Sciences (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

» top